Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8M,First-ever Dividend was HK$0.277 Cents Per Share,Strengthening Presence in Osteoporosis,Ophthalmology, and Aesthetic Medical Markets
2025-03-27
View details2nd December 2024 –Uni-Bio Science Group Limited is pleased to announce two significant milestones that demonstrate the Group’s continued growth and innovation in the field of medical aesthetics and dermatological solutions.
2024-12-02
View detailsAchieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets
2024-08-28
View detailsRecently, Uni-Bio Science Group Limited is pleased to announce a strategic cooperation with Chongqing Minji Medical Device Co., Ltd.
2024-07-10
View detailsRecord-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M,Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets
2024-03-28
View details